• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Current and Future Developments Across the Ophthalmic Pharmaceutical Drugs Market

Posted on: Thursday, 5 April 2007, 06:00 CDT

Reportlinker.com announces that a new market research report related to the worldwide pharmaceutical market is now available to its catalogue.

Ophthalmic Pharmaceutical Drugs

http://www.reportlinker.com/p046356/ophthalmic-drug.html

This report analyzes the worldwide markets for Opthalmic Pharmaceutical Drugs in US$ Million.

The major therapeutic categories analyzed are Glaucoma, Anti-allergy, Anti-infective, Dry Eye, Anti-inflammation, Back of Eye, and Others.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2010.

The report profiles 96 companies including many key and niche players worldwide such as Acuity Pharmaceuticals, Akorn, Inc., Alcon Eye Care, Inc., Allergan, Inc., Alimera Sciences, Inc.. Bausch & Lomb, Inc., Genvec, Inc., Genaera Corporation Inc., GlaxoSmithKline Plc, Inspire Pharmaceuticals, Inc., ISTA Pharmaceuticals, Inc., Merck & Co., Inc., Novartis Pharma AG, Otsuka Pharmaceutical Co., Ltd., Pfizer Inc., QLT, Inc., Santen Pharmaceutical Co., and Santen Inc.

Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Table of content

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. Executive Summary 1. Industry Overview II-1 2. Market Dynamics II-14 3. An Overview of Ophthalmic Drugs II-19 4. Ophthalmic Disorders: A Freeze Frame II-48 5. FDA Regulations And Approvals II-68 6. Product Innovations/Introductions II-73 7. Recent Industry Activity II-76 8. Focus on Select Global Players II-85 9. Global Market Perspective II-92

III. MARKET 1. The United States III-1 2. Canada III-38 3. Japan III-41 4. Europe III-46 5. Asia-Pacific III-65 6. Latin America III-68 7. Rest of World III-70

IV. COMPETITION 1. Acuity Pharmaceuticals, Inc. (USA) IV-1 2. Advanced Medical Optics, Inc. (USA) IV-3 3. Advanced Refractive Technologies, Inc. (USA) IV-8 4. Advanced Vision Research, Inc. (USA) IV-9 5. Akorn, Inc. (USA) IV-11 6. Albany Molecular Research, Inc. (USA) IV-22 7. Alcon, Inc. (USA) IV-26 8. Alimera Sciences (USA) IV-43 9. Allergan, Inc. (USA) IV-45 10. AlphaRx, Inc. (Canada) IV-52 11. Amoun Pharmaceutical Company SAE (Egypt) IV-57 12. Apotex, Inc. (Canada) IV-59 13. Argentis LLC (USA) IV-61 14. Auro Laboratories (India) IV-62 15. Bal Pharma Ltd. (India) IV-63 16. Bausch & Lomb, Inc. (USA) IV-65 17. Bohus Biotech AB (Sweden) IV-73 18. Cadila Pharmaceuticals Ltd. (India) IV-74 19. Ciron Drugs & Pharmaceuticals Pvt., Ltd. (India) IV-75 20. CombinatoRx, Inc. (USA) IV-78 21. Concord Drugs Ltd. (India) IV-79 22. Cynacon/ Ocusoft (USA) IV-81 23. CytoPathfinder, Inc. (Japan) IV-82 24. Dutch Ophthalmic Research Center International BV (The Netherlands) IV-84 25. Erfa SA (Belgium) IV-86 26. Farmak PubJSC (Ukraine) IV-87 27. Farmigea SpA (Italy) IV-88 28. FDC Limited (India) IV-89 29. Fougera/Altana - Fougera Division (USA) IV-91 30. Fovea Pharmaceuticals SA (France) IV-94 31. Galenika A.D. (Serbia and Montenegro) IV-95 32. Genaera Corporation (USA) IV-96 33. Genentech, Inc. (USA) IV-98 34. GenVec, Inc. (USA) IV-105 35. Gland Pharma Ltd. (India) IV-111 36. Glaxosmithkline PLC (UK) IV-112 37. Hemomont D.O.O. (Serbia and Montenegro) IV-124 38. Hi-Tech Pharmacal Co., Inc. (USA) IV-125 39. Holland & Barrett Ltd. (UK) IV-128 40. Indkus Drugs & Pharma Pvt. Ltd. (India) IV-129 41. Indoco Remedies (India) IV-130 42. Insite Vision, Inc. (USA) IV-133 43. Inspire Pharmaceuticals, Inc. (USA) IV-136 44. Intradigm Corporation (USA) IV-139 45. ISTA Pharmaceuticals (USA) IV-140 46. Jelfa SA Przedsiebiorstwo Farmaceutyczne (Poland) IV-144 47. Kalypsys, Inc. (USA) IV-145 48. Laboratorio Edol - Produtos Farmaceuticos SA (Portugal) IV-147 49. Lantibio, Inc. (USA) IV-149 50. Lux Biosciences, Inc. (USA) IV-150 51. Macusight, Inc. (USA) IV-152 52. Merck & Co., Inc. (USA) IV-153 53. Micro Labs (India) IV-163 54. MicroVision, Inc. (USA) IV-164 55. Miravant Medical Technology (USA) IV-170 56. Nascent Pharmaceuticals, Inc. (USA) IV-171 57. NicOx SA (France) IV-172 58. Novagali Pharma SA (France) IV-174 59. Novartis Pharma Switzerland AG (Switzerland) IV-176 60. NPS Pharmaceuticals (USA) IV-192 61. OccuLogix, Inc. (Canada) IV-195 62. OSI Pharmaceuticals (USA) IV-198 63. Othera Pharmaceuticals (USA) IV-201 64. Otsuka Pharmaceutical Co., Ltd. (Japan) IV-202 65. OXiGENE, Inc. (USA) IV-204 66. Par Pharmaceutical Companies, Inc. (USA) IV-206 67. Parenteral Drugs (India) Ltd. (India) IV-210 68. Pathogenics, Inc. (USA) IV-211 69. PediaMed Pharmaceuticals, Inc. (USA) IV-212 70. Pfizer, Inc. (USA) IV-214 71. Pharma Stulln GmbH (Germany) IV-230 72. Pharmadanica A/S (Denmark) IV-231 73. Pharmalab (Australia) IV-232 74. Pharmaster (France) IV-233 75. Polpharma SA Zaklady Farmaceutyczne (Poland) IV-234 76. QLT, Inc. (Canada) IV-236 77. Reckitt Benckiser, Inc. (USA) IV-241 78. Rhein Mina Pharam Biogenetics (Egypt) IV-244 79. Rohto Pharmaceutical Company Ltd. (Japan) IV-245 80. SIFI SpA - Societa Industria Farmaceutica Italiana (Italy) IV-251 81. Sankyo Co., Ltd. (Japan) IV-252 82. Santen Pharmaceutical Co., Ltd. (Japan) IV-255 83. Senju Pharmaceutical (Japan) IV-263 84. Sirion Therapeutics, Inc. (USA) IV-264 85. Spectrum Pharmaceuticals, Inc. (USA) IV-266 86. SRS Pharmaceuticals Pvt., Ltd. (India) IV-270 87. Sucampo Pharmaceuticals, Inc. (USA) IV-274 88. SurModics, Inc. (USA) IV-275 89. Teva Pharmaceuticals USA (USA) IV-282 90. Toyamo Chemical Co., Ltd. (Japan) IV-283 91. TRB Chemedica International SA (Switzerland) IV-284 92. UBE Industries Ltd. (Japan) IV-285 93. Unimed Pharma Sro (Slovakia) IV-293 94. Ursapharm Arzneimittel GmbH & Co., KG. (Germany) IV-293 95. Vistakon Pharmaceuticals LLC (USA) IV-294 96. Vitamed Pharmaceutical Industries Ltd. (Israel) IV-294

More market research reports? Go to http://www.reportlinker.com

http://www.reportlinker.com/Rss/en/index.htm

http://www.reportlinker.com/Rss/fr/index.htm

Source: Business Wire

More News in this Category